Most Read Articles
18 Aug 2018
Despite the absence of a substance use problem, regular cannabis use is associated with psychosocial impairment among adolescents and young adults, a study suggests. On the other hand, regular users with cannabis use disorder appear to exhibit high psychiatric comorbidity and more severe psychosocial impairment.
07 Sep 2018
Children with Down syndrome appear to have an elevated risk of developing severe respiratory syncytial virus (RSV) infection, a study has found.
21 Mar 2018
During the Kuala Lumpur International Neonatology Conference held in conjunction with the World Prematurity Day 2017, Dato Dr Musa Mohd Nordin spoke on the importance of immunizing children with the diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine. He highlighted the role of Hexaxim® as a fully liquid, ready-to-use, 6-in-1 (including hepatitis B) vaccine for the primary and booster vaccinations of infants and toddlers. Meanwhile, Dr Yong Junina Fadzil discussed the benefits of quadrivalent influenza vaccines (QIVs) in providing children with broader protection against influenza B viruses.
Jairia Dela Cruz, 01 Sep 2018
Tight glycaemic control does not yield significant short-term survival gains and risk reductions for infections when compared with a conventional glucose-lowering strategy in critically ill patients in the paediatric intensive care unit, according to a meta-analysis.

Caffeine therapy safe, effective for apnoea of prematurity

13 May 2018

Neonatal caffeine therapy shows promise in the management of apnoea of prematurity in very low birthweight neonates, according to a study. Specifically, it helps improve visuomotor, visuoperceptual and visuospatial abilities at age 11 years without compromising general intelligence, attention and behaviour.

The study randomly assigned 870 children with a birthweight of 500–1,250 g to treatment groups receiving caffeine (a loading dose of 20 mg of caffeine citrate per kilogram of body weight, followed by a daily maintenance dose of 5 mg/kg; n=432) or placebo (equivalent volume of normal saline; n=438). If apnoea persisted, caffeine therapy dose was escalated to a maximum of 10 mg/kg per day. Treatment was initiated at a median age of 3 days and weaned before reaching a median postmenstrual age of 35 weeks.

Outcomes of interest included general intelligence, attention, executive function, visuomotor integration and perception, and behaviour at 11 years of age. Results showed that these neurobehavioral outcomes were generally similar between the caffeine and placebo group.

However, caffeine yielded significantly greater improvements in fine motor coordination (mean difference [MD], 2.9; 95 percent CI, 0.7–5.1; p=0.01), visuomotor integration (MD, 1.8; 0.0–3.7; p<0.05), visual perception (MD, 2.0; 0.3–3.8; p=0.02) and visuospatial organization (MD, 1.2; 0.4–2.0; p=0.003).

None of the outcomes investigated were adversely affected by caffeine. This indicates the long-term safety and efficacy of caffeine therapy for apnoea of prematurity in very low birth weight neonates, as pointed out by researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
18 Aug 2018
Despite the absence of a substance use problem, regular cannabis use is associated with psychosocial impairment among adolescents and young adults, a study suggests. On the other hand, regular users with cannabis use disorder appear to exhibit high psychiatric comorbidity and more severe psychosocial impairment.
07 Sep 2018
Children with Down syndrome appear to have an elevated risk of developing severe respiratory syncytial virus (RSV) infection, a study has found.
21 Mar 2018
During the Kuala Lumpur International Neonatology Conference held in conjunction with the World Prematurity Day 2017, Dato Dr Musa Mohd Nordin spoke on the importance of immunizing children with the diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine. He highlighted the role of Hexaxim® as a fully liquid, ready-to-use, 6-in-1 (including hepatitis B) vaccine for the primary and booster vaccinations of infants and toddlers. Meanwhile, Dr Yong Junina Fadzil discussed the benefits of quadrivalent influenza vaccines (QIVs) in providing children with broader protection against influenza B viruses.
Jairia Dela Cruz, 01 Sep 2018
Tight glycaemic control does not yield significant short-term survival gains and risk reductions for infections when compared with a conventional glucose-lowering strategy in critically ill patients in the paediatric intensive care unit, according to a meta-analysis.